Abstract: A wireless apparatus according to one aspect of the present invention includes a reception unit configured to receive, on a frequency channel, a frame including first identification information for identifying the priority level of the frame, and a carrier sensing control unit configured to determine a threshold based on the first identification information, and determine a usage state of the frequency channel based on a comparison between received power of the frame and the determined threshold.

Abstract: A transmitting station (TX) of an embodiment includes first and second radio signal processing units (STA1 and STA2) and a link management unit (LM). The link management unit establishes multi-link with a receiving station by using the first and second radio signal processing units, and manages communication using the multi-link. The link management unit distributes a plurality of data units to the first and second radio signal processing units. The first radio signal processing unit transmits a first data unit group among the plurality of data units to the receiving station, and transmits first information indicating the sequence number of the data unit included in the first data unit group to the receiving station.

Abstract: A rare earth sintered magnet is produced by depositing a coating of rare earth-containing particles on the surface of a rare earth magnet body, and heat treating the magnet body for causing absorption and diffusion of rare earth element in the magnet body. The depositing step utilizes a particle impingement phenomenon.

Abstract: A compound of formula (I) given below or a pharmaceutically acceptable salt of the compound is useful as an IDO/TDO inhibitor.

Abstract: Provided is a method for using a STAT3 inhibitor which exhibits an excellent antitumor effect. An antitumor agent comprises a quinoline carboxamide derivative of formula (I) below or a salt thereof as an active ingredient, and is administered in combination with an immune checkpoint inhibitor. The antitumor agent is administered before the administration of the immune checkpoint inhibitor.

Abstract: Provided is a method for using a STAT3 inhibitor having a high antitumor effect and little side effects. The antitumor agent comprises a combination of a quinoline carboxamide derivative of formula (I) below or a pharmacologically acceptable salt thereof with one or more cancer molecular target drugs selected from the group consisting of an ALK inhibitor, an EGFR inhibitor, a multi kinase inhibitor, a HER2/EGFR inhibitor, an mTOR inhibitor, a BRAF inhibitor, a MEK inhibitor and a BCR-ABL inhibitor, wherein R1, R2, R3, R4, R5 and R6 are the same or different, and each represent a hydrogen atom, a substituted or unsubstituted aryl group, a substituted or unsubstituted aromatic heterocyclic group, COOR7 (wherein R7 represents a substituted or unsubstituted alkyl group), or OR8 (wherein R8 represents a substituted or unsubstituted alkyl group).

Abstract: To provide an agent for overcoming immunosuppression which can overcome immunosuppression by regulatory T cells. An agent for overcoming immunosuppression and an inhibitor of FOXP3 function containing an anthracycline antibiotic as an active ingredient.

Abstract: A system includes a biological sensor measuring biological data of a plurality of customers, a storage storing a plurality of attendant-associated data records, and a processor. Each attendant-associated data record includes the biological data of a customer, a seat identifier, and an attendant identifier associated with each other. The processor calculates at least one stress indicator of at least one customer. Each stress indicator is calculated based on the biological data in one of at least one attendant-associated data record extracted from the plurality of attendant-associated data records and associated with a first attendant identifier. The processor further calculates an evaluation value indicated by the first attendant identifier based on the at least one stress indicator of the at least one customer. The evaluation value is updated based on a registered evaluation value identified by the first attendant identifier stored in the storage, and the calculated stress indicator.

Abstract: Provided are: a composition having an excellent anti-norovirus effect; use of a theaflavin compound for the preparation of the composition; and a method for preventing infection with a norovirus using a theaflavin compound. A theaflavin compound is used as an active ingredient for preventing infection with a norovirus. The theaflavin compound is preferably used together with an alcohol. The theaflavin compound is preferably one or more members selected from the group consisting of theaflavin, theaflavin-3-O-gallate, theaflavin-3?-O-gallate and theaflavin-3,3?-O-digallate that are derived from tea components.

Abstract: A system includes a biometric sensor that detects biometric data of a person in a first region and a presuming unit that presumes that the person is a person to be tracked based on the biometric data. The system also includes a first camera acquiring first image data of the person in the first region and a second camera acquiring second image data of the person in a second region. The system further includes a monitoring unit that tracks the target person in the second region by checking the second image data with the first image data corresponding to the target person.

Abstract: A stress alleviation system, includes: a biological sensor measuring first biological data of a customer boarding transportation; an action application apparatus provided to a transportation seat and applying an action to the customer for alleviating a stressed state of the customer sitting on the seat; a stress data saver previously saving specific stress data where a customer identifier identifying the customer and a second stress indicator calculated using second biological data measured in past boarding of the customer are associated; a stressed state assessor assessing whether the customer is in the stressed state by calculating a first stress indicator of the customer on board using the first biological data of the customer, and by comparing the first stress indicator with the second stress indicator; and an action controller transmitting a control signal causing the action to the action application apparatus when the customer is assessed as in the stressed state.

Abstract: A compound of formula (I) given below or a pharmaceutically acceptable salt of the compound is useful as an IDO/TDO inhibitor.

Abstract: A device control system including a wearable device and a server. The wearable device includes a device that ejects a fragrance material, a biological sensor, and a computer. The computer transmits biological data to the server, receives a first control signal, and causes the device to eject a fragrance material upon receipt of the first control signal. The server includes a computer. The computer receives the biological data, estimates user's emotion from the received biological data, and in a case where it is determined that the user has positive emotion by using a result of the estimation, (i) transmits the first control signal to the wearable device and (ii) transmits, to an aroma device, a second control signal for causing the aroma device to eject a fragrance material at a predetermined timing.

Abstract: A system includes a biological sensor measuring biological data of a plurality of customers, a storage storing a plurality of attendant-associated data records, and a processor. Each attendant-associated data record includes the biological data of a customer, a seat identifier, and an attendant identifier associated with each other. The processor calculates at least one stress indicator of at least one customer. Each stress indicator is calculated based on the biological data in one of at least one attendant-associated data record extracted from the plurality of attendant-associated data records and associated with a first attendant identifier. The processor further calculates an evaluation value indicated by the first attendant identifier based on the at least one stress indicator of the at least one customer. The evaluation value is updated based on a registered evaluation value identified by the first attendant identifier stored in the storage, and the calculated stress indicator.

Abstract: A flight attendant evaluation system includes: a first biological sensor that measures first biological data of a customer on board transportation; a storage that stores attendant-associated data in which the first biological data, a seat identifier, and an attendant identifier are associated with each other, the seat identifier indicating a seat of the customer on board, the attendant identifier indicating a flight attendant in charge of the seat; an evaluation value calculator that classifies the attendant-associated data by the attendant identifier, calculates a stress indicator of the customer based on the first biological data associated with a first attendant identifier, and calculates an evaluation value of the flight attendant indicated by the first attendant identifier based on the stress indicator; and a display apparatus that presents the evaluation value.

Abstract: This exhaust cam shaft (2) is provided with a shaft part (5) and cam parts (6 to 13) provided on the outer circumference of the shaft part (5). The shaft part (5) has holes (16, 17, 19) opened at predetermined positions on the outer circumferential surface of the shaft part (5). The holes (16, 17, 19) are formed so as to be gradually tapered from an outside of the shaft part (5) toward a center of the shaft part (5) in a radial direction.

Abstract: A system includes a biometric sensor that detects biometric data of a person in a first region and a presuming unit that presumes that the person is a person to be tracked based on the biometric data. The system also includes a first camera acquiring first image data of the person in the first region and a second camera acquiring second image data of the person in a second region. The system further includes a monitoring unit that tracks the target person in the second region by checking the second image data with the first image data corresponding to the target person.

Abstract: A system includes a biometric sensor that detects biometric data of a person in a first region and a presuming unit calculating, from the biometric data, a stress index and presuming that the person is a person to be tracked based on the calculated stress index. The system also includes a first camera acquiring first image data of the person in the first region and a second camera acquiring second image data of the person in a second region. The system further includes a monitoring unit that tracks the target person in the second region by checking the second image data with the first image data corresponding to the target person.

Abstract: A system includes a biometric sensor that detects biometric data of a person in a first region and a presuming unit calculating, from the biometric data, a stress index and presuming that the person is a person to be tracked based on the calculated stress index. The system also includes a first camera acquiring first image data of the person in the first region and a second camera acquiring second image data of the person in a second region. The system further includes a monitoring unit that tracks the target person in the second region by checking the second image data with the first image data corresponding to the target person.

Abstract: A control method comprises: receiving from a first vehicle, first information including a first required amount of the energy source; receiving from a second vehicle, second information including a second required amount of the energy source; and determining, when a total sum of required amounts of the energy source received from two or more vehicles including the first vehicle and the second vehicle is larger than a remaining amount in a storage reservoir, i) a first reserved supply amount of the energy source for the first vehicle, wherein the first reserved supply amount is smaller than the first required amount, and ii) a second reserved supply amount of the energy source for the second vehicle. The second reserved supply amount is determined within a range where a total sum of the first reserved supply amount and the second reserved supply amount does not exceed the remaining amount.